Tag: Share market analysis
-
Sudeep Pharma Soars 29% Above IPO Price: Should Investors Book Profit or Hold?
Sudeep Pharma, a leading manufacturer of specialty chemicals and pharmaceutical excipients, made a strong debut in the stock market with its shares rallying nearly 29% above the IPO price. The company’s impressive listing has generated significant buzz among retail and institutional investors, prompting the key question: Is it time to book profits, or should investors…